Tag: FDA bioequivalence

FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained

FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained

The FDA enforces stricter bioequivalence rules for narrow therapeutic index (NTI) drugs to prevent dangerous fluctuations in blood levels. Learn how these standards differ from regular generics and which medications are affected.

View more